89bio (ETNB) News Today → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free ETNB Stock Alerts $8.86 +0.09 (+1.03%) (As of 06/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 15 at 5:12 AM | marketbeat.comOrchard Capital Management LLC Purchases 196,329 Shares of 89bio, Inc. (NASDAQ:ETNB)Orchard Capital Management LLC boosted its position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 36.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 739,208 shares of the companJune 15 at 4:04 AM | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of 89bio, Inc. (NASDAQ:ETNB - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the seven brokerages that are covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and five have issued a buy rating on the compaJune 14 at 4:05 PM | globenewswire.com89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 14 at 2:45 PM | marketbeat.com89bio (NASDAQ:ETNB) Trading Down 9.1%89bio (NASDAQ:ETNB) Shares Down 9.1%June 13, 2024 | marketbeat.comParkman Healthcare Partners LLC Has $2.45 Million Holdings in 89bio, Inc. (NASDAQ:ETNB)Parkman Healthcare Partners LLC lowered its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 39.6% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 219,448 shares of the company's stock after selling 144,105 shares during the period. Parkman HealthcaJune 13, 2024 | americanbankingnews.comCantor Fitzgerald Reiterates Overweight Rating for 89bio (NASDAQ:ETNB)June 12, 2024 | marketbeat.com89bio (NASDAQ:ETNB) Trading Up 8.8%89bio (NASDAQ:ETNB) Trading 8.8% HigherJune 12, 2024 | marketbeat.com89bio (NASDAQ:ETNB) Receives Overweight Rating from Cantor FitzgeraldCantor Fitzgerald reissued an "overweight" rating and set a $29.00 price objective on shares of 89bio in a report on Wednesday.June 11, 2024 | americanbankingnews.com89bio's (ETNB) "Buy" Rating Reaffirmed at HC WainwrightJune 10, 2024 | marketbeat.com1,021,477 Shares in 89bio, Inc. (NASDAQ:ETNB) Bought by Superstring Capital Management LPSuperstring Capital Management LP bought a new position in 89bio, Inc. (NASDAQ:ETNB - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 1,021,477 shares of the company's stock, valued at approximately $11,410June 7, 2024 | marketbeat.comRTW Investments LP Acquires New Position in 89bio, Inc. (NASDAQ:ETNB)RTW Investments LP acquired a new stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 5,578,931 shares of the company's stock, valued at approximately $62,317,000. 89biJune 7, 2024 | americanbankingnews.com89bio (NASDAQ:ETNB) Shares Gap Down to $8.30June 4, 2024 | marketbeat.com89bio (NASDAQ:ETNB) Stock Price Up 8.3%89bio (NASDAQ:ETNB) Trading Up 8.3%June 3, 2024 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Short Interest Down 5.9% in May89bio, Inc. (NASDAQ:ETNB - Get Free Report) saw a significant decline in short interest during the month of May. As of May 15th, there was short interest totalling 10,120,000 shares, a decline of 5.9% from the April 30th total of 10,750,000 shares. Based on an average daily volume of 1,050,000 shares, the short-interest ratio is presently 9.6 days.May 29, 2024 | marketbeat.comMonashee Investment Management LLC Invests $1.56 Million in 89bio, Inc. (NASDAQ:ETNB)Monashee Investment Management LLC purchased a new position in 89bio, Inc. (NASDAQ:ETNB - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 140,000 shares of the compMay 26, 2024 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Shares Bought by Westfield Capital Management Co. LPWestfield Capital Management Co. LP raised its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 34.2% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 1,761,148 shares of the company's stock after purchasing an additional 449,262 shares during the pMay 26, 2024 | marketbeat.comComerica Bank Boosts Stake in 89bio, Inc. (NASDAQ:ETNB)Comerica Bank lifted its holdings in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 205,071.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 155,930 shares of the company's stock after acquiring an additional 155,854 sharesMay 23, 2024 | marketbeat.com89bio (NASDAQ:ETNB) Stock Price Down 6.6%89bio (NASDAQ:ETNB) Stock Price Down 6.6%May 23, 2024 | seekingalpha.com89bio: Pegozafermin Could Be A Game-Changer For Liver Disease - Strong BuyMay 22, 2024 | globenewswire.com89bio to Present 48-Week Data from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at EASL International Liver CongressMay 17, 2024 | marketbeat.com89bio (NASDAQ:ETNB) Rating Reiterated by Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating and set a $29.00 price target on shares of 89bio in a research report on Friday.May 16, 2024 | markets.businessinsider.comBuy Rating for 89bio on Pegozafermin’s Promise in Advanced NASH TrialsMay 16, 2024 | marketbeat.com89bio (NASDAQ:ETNB) Earns Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $29.00 price objective on shares of 89bio in a report on Thursday.May 15, 2024 | marketbeat.com89bio (NASDAQ:ETNB) Trading Up 5.5%89bio (NASDAQ:ETNB) Stock Price Up 5.5%May 15, 2024 | marketbeat.com89bio (NASDAQ:ETNB) Given New $33.00 Price Target at Evercore ISIEvercore ISI lowered their target price on shares of 89bio from $37.00 to $33.00 and set an "outperform" rating on the stock in a report on Wednesday.May 15, 2024 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) to Post FY2024 Earnings of ($2.30) Per Share, Cantor Fitzgerald Forecasts89bio, Inc. (NASDAQ:ETNB - Free Report) - Stock analysts at Cantor Fitzgerald lowered their FY2024 earnings per share estimates for shares of 89bio in a report issued on Monday, May 13th. Cantor Fitzgerald analyst K. Kluska now expects that the company will earn ($2.30) per share for the year, doMay 15, 2024 | morningstar.com89bio Inc Ordinary SharesMay 14, 2024 | markets.businessinsider.comOppenheimer Reaffirms Their Hold Rating on 89bio (ETNB)May 14, 2024 | globenewswire.com89bio Initiates Phase 3 ENLIGHTEN-Cirrhosis Trial of Pegozafermin in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Patients with Compensated CirrhosisMay 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for 89bio Amid Pegozafermin’s Clinical Advances and Market PotentialMay 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for 89bio Amid Promising Drug Candidate Progress and Strategic ReadinessMay 10, 2024 | finance.yahoo.com89bio Inc (ETNB) Reports Increased Losses in Q1 2024 Despite Advancements in Clinical TrialsMay 10, 2024 | marketbeat.com89bio (NASDAQ:ETNB) Announces Earnings Results89bio (NASDAQ:ETNB - Get Free Report) released its earnings results on Thursday. The company reported ($0.54) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.46) by ($0.08). During the same quarter in the previous year, the firm posted ($0.54) EPS.May 10, 2024 | globenewswire.com89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 10, 2024 | marketbeat.com89bio (NASDAQ:ETNB) PT Lowered to $29.00HC Wainwright cut their price target on 89bio from $31.00 to $29.00 and set a "buy" rating on the stock in a research note on Friday.May 9, 2024 | msn.comETNB Stock Earnings: 89bio Misses EPS for Q1 2024May 9, 2024 | globenewswire.com89bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 8, 2024 | globenewswire.com89bio to Participate in the BofA Securities 2024 Health Care ConferenceMay 2, 2024 | finance.yahoo.com89bio to Host Key Opinion Leader Webinar on Pegozafermin’s Opportunity in Advanced MASHMay 2, 2024 | globenewswire.com89bio to Host Key Opinion Leader Webinar on Pegozafermin's Opportunity in Advanced MASHApril 29, 2024 | marketbeat.comabrdn plc Takes Position in 89bio, Inc. (NASDAQ:ETNB)abrdn plc acquired a new stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 214,192 shares of the company's stock, valued at approximately $2,393,000.April 24, 2024 | investing.comBofA raises 89bio to stock buy amid MASH outlookApril 22, 2024 | finance.yahoo.com89bio, Inc. (ETNB) Stock Historical Prices & Data - Yahoo FinanceApril 22, 2024 | marketbeat.com89bio (NASDAQ:ETNB) Shares Gap Up to $9.0889bio (NASDAQ:ETNB) Shares Gap Up to $9.08April 22, 2024 | marketbeat.comBank of America Reaffirms "Buy" Rating for 89bio (NASDAQ:ETNB)Bank of America reissued a "buy" rating and set a $30.00 target price on shares of 89bio in a report on Monday.April 22, 2024 | marketbeat.comFederated Hermes Inc. Sells 167,035 Shares of 89bio, Inc. (NASDAQ:ETNB)Federated Hermes Inc. trimmed its position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 7.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,962,566 shares of the company's stock after selling 167,035 shaApril 17, 2024 | globenewswire.com89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of DirectorsApril 11, 2024 | marketbeat.com89bio (NASDAQ:ETNB) Stock Price Down 4.2%89bio (NASDAQ:ETNB) Stock Price Down 4.2%April 9, 2024 | marketbeat.comVanguard Group Inc. Increases Stock Holdings in 89bio, Inc. (NASDAQ:ETNB)Vanguard Group Inc. boosted its stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 4.6% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 3,525,782 shares of the company's stock after acquiring an additional 155,841 shares during the quarter. Vanguard GApril 5, 2024 | globenewswire.com89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Get 89bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address Musk’s new company could top a trillion? (Ad)The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. ETNB Media Mentions By Week ETNB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETNB News Sentiment▼0.680.91▲Average Medical News Sentiment ETNB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETNB Articles This Week▼133▲ETNB Articles Average Week Get 89bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Merus News Ultragenyx Pharmaceutical News Prestige Consumer Healthcare News Arrowhead Pharmaceuticals News HUTCHMED News Corcept Therapeutics News Amicus Therapeutics News Biohaven News Dyne Therapeutics News Geron News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETNB) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | Sponsoredonly trade options on these 5-7 stocksI'm going to reveal the only 5-7 stocks you should be trading. But here's the secret - there's nothing spec...Prosper Trading Academy | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | Sponsored